17-36013219-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000615050.2(CCL23):c.392G>A(p.Arg131Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000279 in 1,611,956 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/16 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000615050.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCL23 | NM_005064.6 | c.392G>A | p.Arg131Gln | missense_variant | 4/4 | ENST00000615050.2 | NP_005055.3 | |
CCL23 | NM_145898.4 | c.341G>A | p.Arg114Gln | missense_variant | 4/4 | NP_665905.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCL23 | ENST00000615050.2 | c.392G>A | p.Arg131Gln | missense_variant | 4/4 | 1 | NM_005064.6 | ENSP00000481357 | P2 | |
CCL23 | ENST00000612516.4 | c.341G>A | p.Arg114Gln | missense_variant | 4/4 | 1 | ENSP00000484748 | A2 | ||
CCL23 | ENST00000613876.1 | c.*198G>A | 3_prime_UTR_variant, NMD_transcript_variant | 2/2 | 3 | ENSP00000479076 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152128Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251428Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135896
GnomAD4 exome AF: 0.0000295 AC: 43AN: 1459828Hom.: 0 Cov.: 29 AF XY: 0.0000399 AC XY: 29AN XY: 726388
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152128Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74320
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 05, 2024 | The c.392G>A (p.R131Q) alteration is located in exon 4 (coding exon 4) of the CCL23 gene. This alteration results from a G to A substitution at nucleotide position 392, causing the arginine (R) at amino acid position 131 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at